跳至主要内容
临床试验/NCT00226642
NCT00226642Unknown4 期

Behandlung Von Leichten Und Unterschwelligen Depressionen. Eine Randomisierte, Kontrollierte Studie Zum Wirksamkeitsnachweis Eines Serotonin-Wiederaufnahme-Hemmers (SSRI), Einer Kognitiven Verhaltenstherapie Und Einer Freien Therapiewahl ("Treatment of Mild and Subthreshold Depressive Disorders". A Randomized, Controlled Trial on the Efficacy of a Serotonin-Reuptake-Inhibitor (SSRI), a Cognitive-Behavioral Therapy and of Free Choice Between SSRI and CBT")

Ludwig-Maximilians - University of Munich1 个研究点 分布在 1 个国家目标入组 369 人开始时间: 2005年9月27日最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
369
试验地点
1
主要终点
HAMD (changes between baseline and individual endpoint)

研究概览

简要总结

The purpose of this study is to determine the efficacy of a SSRI, cognitive-bahavioral-therapy and a free choice between SSRI and CBT in a sample of primary care patients suffering from mild to moderate depression.

Hypotheses:

  • SSRI is superior to placebo
  • CBT is superior to a non-specific supporting group therapy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subthreshold and mild depressive disorders including dysthymia (HAMD: 8-22)
  • informed consent

排除标准

  • severe mood disorders
  • bipolar disorder
  • recurrent brief depression
  • suicidality
  • alcohol or drug dependency
  • obsessive-compulsive disorder
  • schizoaffective disorder / schizophrenia
  • pregnancy

结局指标

主要结局

HAMD (changes between baseline and individual endpoint)

IDS (changes between baseline and individual endpoint)

次要结局

  • CGI (changes between baseline and individual endpoint)
  • BDI (changes between baseline and individual endpoint)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验